Current role of ischemia-modified albumin in routine clinical practice

Biomarkers ◽  
2010 ◽  
Vol 15 (8) ◽  
pp. 655-662 ◽  
Author(s):  
Alberto Dominguez-Rodriguez ◽  
Pedro Abreu-Gonzalez
2011 ◽  
Vol 9 (2) ◽  
pp. 223-230 ◽  
Author(s):  
Alberto Dominguez-Rodriguez ◽  
Pedro Abreu-Gonzalez

2021 ◽  
Vol 7 (2) ◽  
Author(s):  
Natanael Parningotan Agung ◽  
Muhammad Hanif Nadhif ◽  
Gampo Alam Irdam ◽  
Chaidir Arif Mochtar

Urology is one of the fields that are always at the frontline of bringing scientific advancements into clinical practice, including 3D printing (3DP). This study aims to discuss and presents the current role of 3D-printed phantoms and devices for organ-specified applications in urology. The discussion started with a literature search regarding the two mentionedtopics within PubMed, Embase, Scopus, and EBSCOhost databases. 3D-printed urological organ phantoms are reported for providing residents new insight regarding anatomical characteristics of organs, either normal or diseased, in a tangible manner. Furthermore, 3D-printed organ phantoms also helped urologists to prepare a pre-surgical planning strategy with detailed anatomical models of the diseased organs. In some centers, 3DP technology also contributed to developing specified devicesfor disease management. To date, urologists have been benefitted by 3D-printed phantoms and devices in the education and disease management of organs of in the genitourinary system, including kidney, bladder, prostate, ureter, urethra, penis, and adrenal. It is safe to say that 3DP technology can bring remarkable changes to daily urological practices.


2015 ◽  
Vol 125 (11) ◽  
pp. 859-866
Author(s):  
Marcia M.M. Pizzichini ◽  
Huib A.M. Kerstjens ◽  
Emilio Pizzichini

2016 ◽  
pp. 109-118
Author(s):  
Campbell S.D. Roxburgh ◽  
Donald C. McMillan

The chapter focuses on the role of immunity and inflammation in established cancer. From the evidence reviewed it is clear that immune and inflammatory responses, innate, humoral and adaptive, local and systemic, are intimately linked to the tumour and themselves and impact on cancer survival. It is also possible to identify key mediators that may be targeted in the cancer patient. However, further work is required to elucidate the mechanisms by which these immune and inflammatory responses are activated, maintained, and interact. Therapeutic intervention using non-selective anti-inflammatory agents is widely advocated and likely to become part of routine clinical practice in the near future. Selective therapeutic intervention directed at the immune and inflammatory responses in cancer is in its infancy. Therefore, it would appear that, at least in non-hereditary disease, immune and inflammatory responses are of key, if not of prime, importance in tumour progression and dissemination.


2011 ◽  
Vol 73 (4) ◽  
pp. AB346-AB347
Author(s):  
Michael M. Einstein ◽  
Shawn M. Hancock ◽  
Hershel Raff ◽  
Patrick Pfau ◽  
Nalini M. Guda ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document